Fellowship · New Haven, CT
Sponsored by Yale-New Haven Hospital
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The New England journal of medicine · 2023 · 303 citations · Michael Recht
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
The New England journal of medicine · 2022 · 352 citations · Lakshmanan Krishnamurti
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B.
The New England journal of medicine · 2025 · 54 citations · Michael Recht
The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus.
Cell · 2023 · 125 citations · Michael DiLuna
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 96 citations · Farzana Pashankar
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 198 citations · Stephanie Massaro
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.
The New England journal of medicine · 2021 · 210 citations · Michael Recht
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
NEJM evidence · 2025 · 39 citations · Nitya Bakshi, Lakshmanan Krishnamurti